Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity
Status:
Completed
Trial end date:
2021-05-21
Target enrollment:
Participant gender:
Summary
This is Open multicenter randomized Phase IV study to evaluate the efficacy and safety of the
drug Reduxin® Forte, film-coated tablets, in comparison with the drug Reduxin®, capsules, in
patients with alimentary obesity was conducted in 5 cities of the Russian Federation (St.
Petersburg, Ivanovo, Kirov, Samara, Rostov-on-Don) on the basis of 8 research centers.